T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Harmony Biosciences
HRMY
$2.32B
| $1M | ﹤0.01% |
36,448
+1,616
| +5% | +$55.7K |
|
|
ODP
2052
DELISTED
ODP
ODP
| $1M | ﹤0.01% |
35,970
+391
| +1% | +$8.03K |
|
2053
RLJ Lodging Trust
RLJ
$1.66B
| $1M | ﹤0.01% |
139,017
+6,355
| +5% | +$47.9K |
|
2054
Vishay Precision Group
VPG
$908M
| $999K | ﹤0.01% |
31,141
+795
| +3% | +$23K |
|
2055
Encore Capital Group
ECPG
$2.07B
| $998K | ﹤0.01% |
23,903
+1,380
| +6% | +$56.7K |
|
|
RWT
2056
Redwood Trust
RWT
$592M
| $996K | ﹤0.01% |
171,875
+4,833
| +3% | +$28.9K |
|
2057
Cimpress
CMPR
$2.4B
| $995K | ﹤0.01% |
15,781
+69
| +0.4% | +$3.87K |
|
2058
Buckle
BKE
$2.33B
| $992K | ﹤0.01% |
16,910
+1,396
| +9% | +$75.5K |
|
2059
SAP
SAP
$242B
| $991K | ﹤0.01% |
3,702
+458
| +14% | +$129K |
|
2060
Cohu
COHU
$2.76B
| $990K | ﹤0.01% |
48,659
+1,847
| +4% | +$37.3K |
|
2061
Adtran
ADTN
$665M
| $989K | ﹤0.01% |
105,428
+2,137
| +2% | +$19.9K |
|
2062
Liberty Latin America Class C
LILAK
$1.67B
| $989K | ﹤0.01% |
128,860
+3,914
| +3% | +$26.7K |
|
2063
Sprinklr
CXM
$1.58B
| $987K | ﹤0.01% |
127,722
-182,324
| -59% | -$1.54M |
|
2064
PagSeguro Digital
PAGS
$2.4B
| $985K | ﹤0.01% |
98,473
+9,575
| +11% | +$86.2K |
|
2065
Stepan Co
SCL
$1.48B
| $984K | ﹤0.01% |
20,622
+1,006
| +5% | +$52.2K |
|
2066
Garrett Motion
GTX
$5.47B
| $982K | ﹤0.01% |
72,085
+8,668
| +14% | +$110K |
|
2067
Evolent Health
EVH
$471M
| $980K | ﹤0.01% |
115,760
+9,998
| +9% | +$97K |
|
|
DHC
2068
Diversified Healthcare Trust
DHC
$2.02B
| $977K | ﹤0.01% |
221,366
+17,390
| +9% | +$66.2K |
|
2069
Enact Holdings
ACT
$6.79B
| $976K | ﹤0.01% |
25,451
+1,338
| +6% | +$49.6K |
|
|
DVAX
2070
DELISTED
Dynavax Technologies
DVAX
| $975K | ﹤0.01% |
98,087
+7,260
| +8% | +$75.6K |
|
2071
Hovnanian Enterprises
HOV
$793M
| $975K | ﹤0.01% |
7,584
+213
| +3% | +$28.4K |
|
2072
Willdan Group
WLDN
$1.29B
| $974K | ﹤0.01% |
10,065
-1,672
| -14% | -$158K |
|
|
ALX
2073
Alexander's
ALX
$1.39B
| $970K | ﹤0.01% |
4,133
+90
| +2% | +$21.1K |
|
2074
Edgewell Personal Care
EPC
$1.32B
| $970K | ﹤0.01% |
47,615
+117
| +0.2% | +$2.75K |
|
2075
Brown-Forman Class A
BF.A
$13B
| $969K | ﹤0.01% |
36,000
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.